Inspire Investing’s Collegium Pharmaceutical COLL Stock Holding History

Inspire Investing’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.07K	Hold	113	–	–	﹤0.01%	1140
2026 Q1	$3.72K	Hold	113	–	–	﹤0.01%	984
2025 Q4	$5.21K	Buy	+113	New	+$4.73K	﹤0.01%	953
2024 Q4	–	Sell	-8,813	Closed	-$341K	–	831
2024 Q3	$341K	Sell	8,813 -15,985	-64%	-$570K	0.03%	756
2024 Q2	$798K	Buy	24,798 +2,917	+13%	+$101K	0.09%	242
2024 Q1	$849K	Sell	21,881 -3,486	-14%	-$122K	0.09%	264
2023 Q4	$781K	Sell	25,367 -2,473	-9%	-$61.9K	0.09%	251
2023 Q3	$622K	Buy	27,840 +873	+3%	+$19.9K	0.08%	258
2023 Q2	$580K	Buy	+26,967	New	+$612K	0.07%	265

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Inspire Investing's COLL Position: Q2 2026 in Review

Inspire Investing held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 113 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Inspire Investing first reported a position in COLL in Q2 2023 and has held it in 9 quarters since. The position peaked at $849K in Q1 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Inspire Investing held 113 shares of Collegium Pharmaceutical worth $4.07K as of Q2 2026.
Inspire Investing left its Collegium Pharmaceutical share count unchanged in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1140 holding.
Inspire Investing first reported a position in Collegium Pharmaceutical in Q2 2023 and has held it in 9 quarters since.
Inspire Investing's Collegium Pharmaceutical position peaked at $849K in Q1 2024.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.